Navigation Links
Performing surgery on a beating heart may be safer

According to a review of the latest clinical trials, coronary artery bypass surgery performed on a beating heart, without the aid of a heart-lung machine, is a safe option that leads to fewer negative side effects for bypass patients. This review is featured in Journal of Cardiac Surgery.

“Previously, it was more common for doctors to perform artery bypass surgery on the heart by stopping the heart and passing the blood through a heart-lung machine,?says author Dr. Shahzad Raja. “However, this process frequently leads to ‘whole body inflammation,?which includes complications such as brain swelling, heart arrhythmia and infections.?According to Raja, performing the surgery on the beating heart, while more technically challenging for the surgeon, keeps these side effects low and allows for a quicker recovery.

“If the surgeons are skilled enough to perform the surgery without stopping the heart, it can be offered to high-risk patients who would not be likely to survive the side effects of the traditional stopped-heart method,?says Raja. “For this reason, quality training needs to be provided for those surgeons who wish to offer this option to their patients.?


'"/>

Source:Blackwell Publishing Ltd.


Page: 1

Related biology news :

1. Performing monkeys in Asia carry viruses that could jump species to humans
2. Rare surgery performed to remove pancreas, prevent diabetes
3. Scalpel-free surgery could reduce risk of HIV and hepatitis exposure for health care workers
4. 3D ultrasound device poised to advance minimally invasive surgery
5. For one Stanford doctor, the beat goes on during open-heart surgery
6. Unique equine cataract surgery offered on routine basis
7. Cheaper and simpler keyhole surgery
8. Robot assisted surgery more accurate than conventional surgery
9. U of MN uses robotic surgery techniques in cardiac cell therapy research
10. New biologic treatment for tennis elbow may replace surgery for chronic sufferers
11. Jefferson scientists find high glucose before surgery raises risk of dangerous complications
Post Your Comments:
Breaking Biology Technology:Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6